{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:52:21Z","timestamp":1792691541209,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003803","name":"University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003802","name":"University Research Committee, University of Hong Kong","doi-asserted-by":"publisher","award":["2202100724"],"award-info":[{"award-number":["2202100724"]}],"id":[{"id":"10.13039\/501100003802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jconrel.2025.113939","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T11:30:43Z","timestamp":1749209443000},"page":"113939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Intravitreal injection of cell membrane-coated nanoparticles for retinoblastoma treatment"],"prefix":"10.1016","volume":"385","author":[{"given":"Yichi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiqi","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Yi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyou","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.113939_bb0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-1-31","article-title":"Retinoblastoma","volume":"1","author":"Aerts","year":"2006","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jconrel.2025.113939_bb0010","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(11)61137-9","article-title":"Retinoblastoma","volume":"379","author":"Dimaras","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.113939_bb0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/aorn.12896","article-title":"An overview of retinoblastoma and enucleation in pediatric patients","volume":"111","author":"Leclerc","year":"2020","journal-title":"AORN J."},{"key":"10.1016\/j.jconrel.2025.113939_bb0020","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archopht.126.6.862","article-title":"The adverse events of chemotherapy for retinoblastoma: what are they? Do we know?","volume":"126","author":"Rizzuti","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2025.113939_bb0025","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3390\/pharmaceutics14061267","article-title":"Effects of flow hydrodynamics and eye movements on intraocular drug clearance","volume":"14","author":"Velentza-Almpani","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113939_bb0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.addr.2012.09.006","article-title":"Nanoparticles in cancer therapy and diagnosis","volume":"64","author":"Brigger","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113939_bb0035","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.phrs.2010.03.005","article-title":"Targeting nanoparticles to cancer","volume":"62","author":"Wang","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2025.113939_bb0040","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1039\/C9BM01392J","article-title":"Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery","volume":"8","author":"Wang","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2025.113939_bb0045","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1021\/acsnano.1c00680","article-title":"Targeted noninvasive treatment of choroidal neovascularization by hybrid cell-membrane-cloaked biomimetic nanoparticles","volume":"15","author":"Li","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113939_bb0050","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.apsb.2021.10.022","article-title":"Intravenous route to choroidal neovascularization by macrophage-disguised nanocarriers for mTOR modulation","volume":"12","author":"Xia","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2025.113939_bb0055","doi-asserted-by":"crossref","first-page":"7750","DOI":"10.1021\/acsnano.3c00470","article-title":"Camouflage nanoparticles enable in situ bioluminescence-driven optogenetic therapy of retinoblastoma","volume":"17","author":"Ding","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113939_bb0060","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3390\/cancers11121836","article-title":"Cancer cell membrane-coated nanoparticles for cancer management","volume":"11","author":"Harris","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2025.113939_bb0065","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.7150\/thno.34837","article-title":"Homotypic cell membrane-cloaked biomimetic nanocarrier for the targeted chemotherapy of hepatocellular carcinoma","volume":"9","author":"Liu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.113939_bb0070","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.biomaterials.2017.07.026","article-title":"Cancer cell membrane-coated biomimetic platform for tumor targeted photodynamic therapy and hypoxia-amplified bioreductive therapy","volume":"142","author":"Li","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.113939_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201905671","article-title":"Cancer cell membrane-coated nanoparticles for personalized therapy in patient-derived xenograft models","volume":"29","author":"Rao","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.113939_bb0080","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/med.21971","article-title":"(Nano)platforms in breast cancer therapy: drug\/gene delivery, advanced nanocarriers and immunotherapy","volume":"43","author":"Ashrafizadeh","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2025.113939_bb0085","first-page":"1003","article-title":"Characterization of a new continuous cell line derived from a human retinoblastoma1","volume":"37","author":"McFall","year":"1977","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113939_bb0090","first-page":"95","article-title":"Molecular mechanisms of etoposide","volume":"14","author":"Montecucco","year":"2015","journal-title":"EXCLI J."},{"key":"10.1016\/j.jconrel.2025.113939_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf7820","article-title":"Genetically engineered cell membrane\u2013coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs","volume":"7","author":"Park","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.113939_bb0100","article-title":"Green light-triggered intraocular drug release for intravenous chemotherapy of retinoblastoma","volume":"8","author":"Long","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.113939_bb0105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113939_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202001808","article-title":"Engineered cell-membrane-coated nanoparticles directly present tumor antigens to promote anticancer immunity","volume":"32","author":"Jiang","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113939_bb0115","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1021\/nl500618u","article-title":"Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery","volume":"14","author":"Fang","year":"2014","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.113939_bb0120","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2217\/nnm.11.19","article-title":"Nanoparticle PEGylation for imaging and therapy","volume":"6","author":"Jokerst","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.113939_bb0125","first-page":"5139","article-title":"Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo","volume":"62","author":"Zitzmann","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113939_bb0130","doi-asserted-by":"crossref","first-page":"8957","DOI":"10.1039\/D2CS00722C","article-title":"Near-infrared (NIR) fluorescence-emitting small organic molecules for cancer imaging and therapy","volume":"51","author":"Li","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2025.113939_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114821","article-title":"Recent progress in NIR-II fluorescence imaging-guided drug delivery for cancer theranostics","volume":"197","author":"Roy","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113939_bb0140","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/cancers11010068","article-title":"Targeted delivery to tumors: multidirectional strategies to improve treatment efficiency","volume":"11","author":"Kutova","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2025.113939_bb0145","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/aos.13417","article-title":"Topical antibiotics and intravitreal injections","volume":"96","author":"Hunyor","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jconrel.2025.113939_bb0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:16:02Z","timestamp":1778944562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925005590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":30,"alternative-id":["S0168365925005590"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113939","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal injection of cell membrane-coated nanoparticles for retinoblastoma treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113939","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113939"}}